ANNA STEPHENSON: Open Payments
NPI 1699372466 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$544 in 28 payments from 14 companies in 2025. Trend: 2023 $495 · 2024 $1,131 · 2025 $544
Food & beverage: $544
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $80 |
| Novo Nordisk Inc | 4 | $78 |
| PFIZER INC. | 3 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $47 |
| ABBVIE INC. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $34 |
| Amgen Inc. | 2 | $31 |
| ALK-Abello, Inc | 1 | $29 |
| Dexcom, Inc. | 1 | $24 |
Products named: MOUNJARO, JARDIANCE, Kerendia, Ozempic, VRAYLAR, NURTEC ODT, Veozah, NEFFY.
Industry payments across NC — which companies pay providers there.
